SCHEMBL80315

SCHEMBL80315

CCCCCCCCCCCCOCC(O)C[N+](CCC)(CCC)CCCP(=O)(O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR5 Q9H1C0 4/20 0.55
USP2 O75604 1/20 0.48
HTT P42858 1/20 0.47
LPAR3 Q9UBY5 8/20 0.44
LPAR1 Q92633 5/20 0.44
LPAR2 Q9HBW0 4/20 0.44
P2RY10 O00398 1/20 0.43
PLA2G2C Q5R387 3/20 0.41
PLA2G2D Q9UNK4 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
LPAR6 P43657 3/20 0.39
LPAR4 Q99677 3/20 0.39
AKT1 P31749 2/20 0.38
PLCG2 P16885 1/20 0.38
PIK3R1 P27986 1/20 0.38
AKT2 P31751 1/20 0.38
PIK3CA P42336 1/20 0.38
AKT3 Q9Y243 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL9053410 0.90 LPAR5 (0.61) LPAR5USP2HTTLPAR3LPAR1
SCHEMBL2454903 0.90 LPAR5 (0.52) LPAR5USP2HTTLPAR3LPAR1
Phosphoric Acid SCHEMBL409139 0.88 LPAR5 (0.58) LPAR5USP2HTTLPAR3LPAR1
SCHEMBL1445519 0.86 USP2 (0.62) LPAR5USP2HTTLPAR3LPAR1
SCHEMBL409138 0.86 LPAR5 (0.64) LPAR5USP2HTTLPAR3LPAR1
SCHEMBL7199096 0.79 USP2 (0.48) LPAR5USP2HTTLPAR3LPAR1
SCHEMBL1086079 0.79 LPAR5 (0.65) LPAR5USP2HTTLPAR3LPAR1
SCHEMBL1086081 0.79 LPAR5 (0.65) LPAR5USP2HTTLPAR3LPAR1
SCHEMBL3827039 0.77 LPAR5 (0.40) LPAR5USP2HTTP2RY10PLA2G2C
SCHEMBL9608647 0.77 USP2 (0.64) LPAR5USP2HTTLPAR3LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1091 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268765-B2 Mono-, di- and polyol phosphate esters in personal care formulations RHODIA OPERATIONS (FR) 2012-09-18 US claimed
US-7666824-B2 skin wash products that include a skin benefit ingredient, such as a barrier enhancing agent, that can be easily transferred to the skin from the wash product; liquid phase containing sterols and natural fat or oil; microencapsulated KIMBERLY-CLARK WORLDWIDE, INC. (US) 2010-02-23 US claimed
US-7268104-B2 Color changing liquid cleansing products KIMBERLY-CLARK WORLDWIDE, INC. (US) 2007-09-11 US claimed
EP-1678289-B1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES COLGATE PALMOLIVE CO (US) 2007-04-11 EP claimed
EP-1395235-B1 SHAMPOOS WITH BEHENYL ALCOHOL COLGATE PALMOLIVE CO (US) 2007-02-28 EP claimed
EP-1678289-A1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES Colgate-Palmolive Company (US) 2006-07-12 EP claimed
US-7045491-B2 Bar soap composition with reduced bar wear properties COLGATE-PALMOLIVE COMPANY (US) 2006-05-16 US claimed
WO-2005107691-A1 LAMELLAR STRUCTURED LIQUID CLEANSER COMPOSITIONS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2005-11-17 WO claimed
US-20050239669-A1 skin wash products that include a skin benefit ingredient, such as a barrier enhancing agent, that can be easily transferred to the skin from the wash product; liquid phase containing sterols and natural fat or oil; microencapsulated KIMBERLY-CLARK WORLDWIDE, INC. 2005-10-27 US claimed
WO-2005067875-A1 COLOR CHANGING LIQUID CLEANSING PRODUCTS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2005-07-28 WO claimed
US-20050148490-A1 Color changing liquid cleansing products KIMBERLY-CLARK WORLDWIDE, INC. 2005-07-07 US claimed
US-20050107273-A1 Bar soap composition with reduced bar wear properties COLGATE-PALMOTIVE COMPANY 2005-05-19 US claimed
WO-2005044970-A1 BAR SOAP COMPOSITION WITH REDUCED BAR WEAR PROPERTIES COLGATE-PALMOLIVE COMPANY (US) 2005-05-19 WO claimed
US-6838420-B2 A translucent or transparent composition comprising about 3 to about 40 wt. % soap, about 4 to about 40 wt. % of at least one synthetic surfactant, and water, lower monohydric alcohol, a humectant, a structurant, and gellant are not 0 at the COLGATE-PALMOLIVE COMPANY (US) 2005-01-04 US claimed
EP-0915693-B1 AN OIL-IN-WATER EMULSION FOR USE ON HUMAN SKIN FOR CLEANSING, PRESERVING OR IMPROVING THE CONDITION OF THE SKIN PLUM KEMI PRODUKTION AS (DK) 2003-10-01 EP claimed
US-6608011-B2 Cleaning compounds comprising mixtures of water, stabilizer agent, buffers, preservatives, anionic, nonionic, amphoteric and cationic surfactants used as hair conditioners, soaps or gels COLGATE-PALMOLIVE COMPANY 2003-08-19 US claimed
EP-3743493-B1 SOLIDIFYING LIQUID ANIONIC SURFACTANTS ECOLAB USA INC (US) 2024-07-17 EP disclosed
US-12037497-B2 Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface KIMBERLY CLARK CO (US) 2024-07-16 US disclosed
US-3937807-A BISBIGUANIDE COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1976-02-10 US disclosed
US-3934002-A BIS-GUANIDE THE PROCTER & GAMBLE COMPANY (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107273-A1 Bar soap composition with reduced bar wear properties DDHD2, SORD, CRABP2 LPAR5 2853/4885USP2 929/4885HTT 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.